澳大利亚在获得老年人使用精神药物的同意方面存在问题。

Australia's problem with obtaining consent for psychotropic use in older people.

机构信息

Capacity Australia, Sydney, New South Wales, Australia.

Department of the School of Psychiatry, UNSW Sydney, Sydney, New South Wales, Australia.

出版信息

Intern Med J. 2021 Apr;51(4):604-607. doi: 10.1111/imj.15274.

DOI:10.1111/imj.15274

PMID:33890367

Abstract

Frequent use of psychotropic medicines in people with dementia is a significant concern globally, doing this without informed consent is a violation of human rights, ethics and law. Capacity Australia piloted an intervention to address several hypothetical barriers to obtaining consent for psychotropic use in aged care and has developed a suite of resources to improve rights and health literacy for clinicians, patients and community alike.

摘要

在全球范围内，痴呆症患者频繁使用精神药物是一个重大问题，未经知情同意就这么做是侵犯人权、违反伦理和法律的行为。澳大利亚能力中心（Capacity Australia）开展了一项干预措施，以解决在老年护理中获得精神药物使用同意方面的几个假设性障碍，并开发了一系列资源，以提高临床医生、患者和社区的权利和健康素养。